{"id":53990,"date":"2023-02-16T12:06:05","date_gmt":"2023-02-16T11:06:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/"},"modified":"2023-02-16T12:06:05","modified_gmt":"2023-02-16T11:06:05","slug":"modular-devices-invests-in-interim-diagnostic-imaging","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/","title":{"rendered":"Modular Devices Invests In Interim Diagnostic Imaging"},"content":{"rendered":"
\n

BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–#O2Investment<\/a>–Modular Devices (www.modulardevices.com<\/a> | www.portable-cleanroom.com<\/a>), a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners (www.o2investment.com<\/a>), announced today that it has partnered with Interim Diagnostic Imaging (www.interimdiagnosticimaging.com<\/a>).\n<\/p>\n

<\/a><\/p>\n

\nLynn Behrns, President of Interim Diagnostic Imaging, commented, \u201cThe partnership with Modular Devices came at an opportune time when Interim Diagnostic Imaging is pursuing an aggressive growth strategy of adding more mobile labs to the fleet. We look forward to combining forces with Modular Devices to become one of the largest lessors of medical imaging suites in the country.\u201d\n<\/p>\n

\nGreg Mink, CEO of Modular Devices, noted, \u201cThe addition of Interim Diagnostic Imaging significantly increases Modular Devices\u2019 fleet while providing diversification and improving our product offering. The combined company will now offer our customers a full range of medical imaging labs including catheterization, cleanroom, PET\/CT, MRI, and CT. We are excited to better serve our customers and execute our expansion strategy.\u201d\n<\/p>\n

\nPat Corden of O2 Investment Partners added, \u201cWe are excited to bring Interim Diagnostic Imaging and Modular Devices together. IDI\u2019s reputation and performance in the mobile CT and MRI market is highly complementary to our growing platform. Interim Diagnostic Imaging joining the platform marks the second investment for Modular Devices within a 12-month period. We look forward to working together towards an exciting future.\u201d\n<\/p>\n

\nAbout Modular Devices
\n
<\/b>Founded in 1987, Modular Devices (\u201cModular\u201d or the \u201cCompany\u201d) is a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions throughout the United States. Modular\u2019s medical imaging solutions offer various imaging modalities through short- and long-term leases to healthcare systems of all sizes. Modular is the only company offering modular cath labs as a stock-standard product available for rent. The Company\u2019s cleanroom division serves the pharmaceutical, biotechnology, and manufacturing sectors by providing standard and customized pre-certified ISO and USP compliant units for lease and for sale. Modular is headquartered in Indianapolis, IN. Additional information available at www.modulardevices.com<\/a>; www.portable-cleanroom.com<\/a>.\n<\/p>\n

\nAbout Interim Diagnostic Imaging
\n
<\/b>Interim Diagnostic Imaging (\u201cIDI\u201d) is a best-in-class provider of mobile CT and MRI medical imaging labs in the United States and Canada. For almost 20 years, IDI has been hospitals\u2019 preferred choice when considering short- and long-term medical imaging suite rentals. IDI is headquartered in Plymouth, MN. Additional information available at www.interimdiagnosticimaging.com<\/a>.\n<\/p>\n

\nAbout O2 Investment Partners
\n
<\/b>O2 Investment Partners is a Midwestern based private equity firm that seeks to acquire majority interests in lower middle market B2B services, technology, and select industrial companies. The firm invests in businesses with earnings growth potential and a clear path to the creation of shareholder value. O2 invests with a view toward partnering with management to build and grow the business and take it to its next stage of development. This requires not only a clear vision and strategic plan to create shareholder value, but a close partnership and alignment of interest with management. Additional information available at www.o2investment.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nO2 Investment Partners<\/b>
Pat Corden
\n
pcorden@o2investment.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–#O2Investment–Modular Devices (www.modulardevices.com | www.portable-cleanroom.com), a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners (www.o2investment.com), announced today that it has partnered with Interim Diagnostic Imaging (www.interimdiagnosticimaging.com). Lynn Behrns, President of Interim Diagnostic Imaging, commented, \u201cThe partnership with Modular Devices came … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53990","6":"format-standard","7":"category-industry"},"yoast_head":"\nModular Devices Invests In Interim Diagnostic Imaging - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Modular Devices Invests In Interim Diagnostic Imaging - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–#O2Investment–Modular Devices (www.modulardevices.com | www.portable-cleanroom.com), a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners (www.o2investment.com), announced today that it has partnered with Interim Diagnostic Imaging (www.interimdiagnosticimaging.com). Lynn Behrns, President of Interim Diagnostic Imaging, commented, \u201cThe partnership with Modular Devices came ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T11:06:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230216005105\/en\/1714993\/21\/O2_Logo_MPC.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Modular Devices Invests In Interim Diagnostic Imaging\",\"datePublished\":\"2023-02-16T11:06:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/\"},\"wordCount\":531,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005105\\\/en\\\/1714993\\\/21\\\/O2_Logo_MPC.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/\",\"name\":\"Modular Devices Invests In Interim Diagnostic Imaging - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005105\\\/en\\\/1714993\\\/21\\\/O2_Logo_MPC.jpg\",\"datePublished\":\"2023-02-16T11:06:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005105\\\/en\\\/1714993\\\/21\\\/O2_Logo_MPC.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005105\\\/en\\\/1714993\\\/21\\\/O2_Logo_MPC.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/modular-devices-invests-in-interim-diagnostic-imaging\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Modular Devices Invests In Interim Diagnostic Imaging\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Modular Devices Invests In Interim Diagnostic Imaging - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/","og_locale":"en_US","og_type":"article","og_title":"Modular Devices Invests In Interim Diagnostic Imaging - Pharma Trend","og_description":"BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–#O2Investment–Modular Devices (www.modulardevices.com | www.portable-cleanroom.com), a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions, and portfolio company of O2 Investment Partners (www.o2investment.com), announced today that it has partnered with Interim Diagnostic Imaging (www.interimdiagnosticimaging.com). Lynn Behrns, President of Interim Diagnostic Imaging, commented, \u201cThe partnership with Modular Devices came ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-16T11:06:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230216005105\/en\/1714993\/21\/O2_Logo_MPC.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Modular Devices Invests In Interim Diagnostic Imaging","datePublished":"2023-02-16T11:06:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/"},"wordCount":531,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230216005105\/en\/1714993\/21\/O2_Logo_MPC.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/","url":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/","name":"Modular Devices Invests In Interim Diagnostic Imaging - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230216005105\/en\/1714993\/21\/O2_Logo_MPC.jpg","datePublished":"2023-02-16T11:06:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230216005105\/en\/1714993\/21\/O2_Logo_MPC.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230216005105\/en\/1714993\/21\/O2_Logo_MPC.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/modular-devices-invests-in-interim-diagnostic-imaging\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Modular Devices Invests In Interim Diagnostic Imaging"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53990"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53990\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}